Exscientia plc (EXAI) Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Exscientia plc (“Exscientia” or “the Company”) (NASDAQ: EXAI). Investors who purchased Exscientia securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/EXAI.

Investigation Details:

On February 13, 2024, Exscientia issued a press release “announc[ing] that its Board of Directors (the ‘Board’) has decided to terminate the employment of Andrew Hopkins as the Company’s Chief Executive Officer and Principal Executive Officer, and to remove Dr. Hopkins from his role as an Executive Director of the Board, in each case for cause and effective immediately. The Board’s decision was taken following an investigation which found that Dr. Hopkins had engaged in relationships with two employees that the Board determined were inappropriate and inconsistent with the Company’s standards and values.” On this news, Exscientia’s stock price fell sharply during intraday trading on February 13, 2024.

What’s Next?

If you are aware of any facts relating to this investigation or purchased Exscientia securities, you can assist this investigation by visiting the firm’s site: bgandg.com/EXAI. You can also contact Peretz Bronstein or his law clerk and client relations manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660.

There is No Cost to You

We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman:

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.

Attorney advertising. Prior results do not guarantee similar outcomes.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240226319662/en/

The Exscientia Stock at the time of publication of the news with a fall of -2,46 % to 5,95USD on Tradegate stock exchange (26. Februar 2024, 09:51 Uhr).